Dagmar Eßl, Medical Scientific Liaison Manager Hematology at Sanofi Genzyme, shared on LinkedIn:
“Four days of scientific exchange, latest data and emerging treatment strategies in hematology and oncology – from multiple myeloma to rare diseases.
Valuable discussions with clinicians and researchers highlight the importance of translating scientific advances into meaningful improvements for patients.”
You can also read:
Myeloma Paper of the Day, October 12th, Suggested by Robert Orlowski
